Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinling Dampness Expelling Granules is a Traditional Chinese Medicine (TCM) formulation developed by the Guangdong Provincial Hospital of Chinese Medicine. It is specifically designed to treat "Dampness Syndrome" in patients with prediabetes. The granules are being evaluated in clinical trials to determine their efficacy in improving glucose metabolism and preventing the progression to type 2 diabetes when combined with lifestyle interventions. As a TCM product, its mechanism likely involves a multi-target approach characteristic of herbal polypharmacology, aimed at resolving dampness and regulating metabolic functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yinling Dampness Expelling Granules.